Researchers engaged in mosquito gene drive technologies are optimistic that new World Health Organization (WHO) guidance on best research practices will ensure that their work is safe and ethical. Such guidance also helps research results advance from laboratories to be used in the field,  the researchers told Health Policy Watch. Due to limiting regulatory frameworks, […] Continue reading ->
A Friday session of the 74th World Health Assembly discussed a report on antimicrobial resistance (AMR) and multi-sectoral approaches to address it. Speakers generally supported a One Health approach involving multiple agencies concerned with communicable diseases, environment, water and food.  This approach recognises the interconnectedness of people with environments and other animals. The World Health […] Continue reading ->
Bold decisions are required to strengthen the World Health Organization and equip it with authority and resources it needs to address glaring shortcomings in pandemic preparedness and response, the 74th World Health Assembly was told on Tuesday. Recommendations emerging out of a report by the Independent Oversight and Advisory Committee (IOAC) for the WHO Health […] Continue reading ->
A sugar tax that generated R3-billion in revenue for South Africa in one year and a mandatory minimum unit price for alcohol products that contributed to a 10% decrease in alcohol-related deaths in Scotland are two examples of proven  successful policies governments have adopted for products that negatively impact health and that have helped raise […] Continue reading ->
Johnson & Johnson will supply COVAX 200 million of its single-dose COVID-19 vaccines by the end of the year, according to a statement on Friday by Gavi, the Vaccine Alliance, announcing the advance purchase agreement. The vaccine will be available to both COVAX members who buy their own vaccines and the COVAX AMC members.  “Today’s […] Continue reading ->
Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which  further exacerbates inequality and lack of access to vaccines for vulnerable groups.  That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading ->
Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading ->